52378-64-0 Usage
Uses
Used in Organic Synthesis:
(3-bromopyridin-2-yl)methanol is used as a building block for the synthesis of various biologically active compounds and pharmaceuticals. Its unique structure, including a bromine atom and a pyridine ring, allows for the creation of a wide range of organic compounds with potential applications in different industries.
Used in Medicinal Chemistry:
(3-bromopyridin-2-yl)methanol is used as a key intermediate in the development of new drugs and therapeutic agents. Its structure provides opportunities for the design and synthesis of novel pharmaceuticals with potential applications in treating various medical conditions.
Used in the Preparation of Heterocyclic Compounds:
(3-bromopyridin-2-yl)methanol is used as a reagent in the preparation of different heterocyclic compounds. Its presence in the synthesis process contributes to the formation of complex molecular structures with potential applications in various fields, including pharmaceuticals, agrochemicals, and materials science.
Used as a Reagent in Chemical Reactions:
(3-bromopyridin-2-yl)methanol is utilized as a reagent in various chemical reactions, facilitating the formation of desired products. Its unique structure allows it to participate in a range of reactions, making it a valuable tool in the synthesis of complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 52378-64-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,3,7 and 8 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 52378-64:
(7*5)+(6*2)+(5*3)+(4*7)+(3*8)+(2*6)+(1*4)=130
130 % 10 = 0
So 52378-64-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H6BrNO/c7-5-2-1-3-8-6(5)4-9/h1-3,9H,4H2
52378-64-0Relevant academic research and scientific papers
IMIDAZOPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER
-
Paragraph 00171, (2018/04/12)
A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R3, R4, R6, and R7 are as defined herein.
TRIAZOLOPYRIDINE COMPOUNDS AND USES THEREOF
-
Paragraph 00169, (2018/04/11)
A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R6, R7 and R8 are as defined herein.
TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF
-
Paragraph 0361; 0363, (2016/07/27)
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.
